CLDN6 and breast carcinoma: Lu et al. demonstrated that SMAD2 causes downregulation of claudin-6 by DNA (cytosine-5)-methyltransferase 1 (DNMT1)-mediated DNA methylation, which results in increased migration and invasion of breast cancer cells [105].